Wockhardt board approves plan to raise Rs 150 crore via securities
Drug firm Wockhardt on Friday said its board has approved plans to raise up to Rs 150 crore by issuing securities on a private placement basis.
May 21, 2021, 22:04 PM IST
Wockhardt seeks shareholders' nod to raise up to Rs 1,000 crore
Drug firm Wockhardt is seeking shareholders' nod to raise up to Rs 1,000 crore via issue of securities.
May 08, 2017, 13:30 PM IST
Drugs ban: Partial relief from HC for Wockhardt,Glaxo & Griffon
Delhi High Court today stayed the the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
Mar 18, 2016, 16:13 PM IST
India drugmaker stocks exception in Asian rout
In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.
Sep 03, 2015, 19:37 PM IST
India drugmaker stocks exception in Asian rout
Continued strength in the dollar when the Federal Reserve raises interest rates will also boost their income. More than 40 percent of over-the-counter and generic prescription drugs sold in the United States come from India.
Sep 03, 2015, 08:14 AM IST
Sun, Wockhardt recall drugs from US market
Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of drugs from the US market due to different reasons.
Aug 30, 2015, 13:28 PM IST
Wockhardt recalls over 50 lakh bottles of various drugs in US
Wockhardt is recalling over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer, in the US market due to deviations in current good manufacturing practice norms laid down by the American health regulator.
Aug 03, 2015, 22:59 PM IST
USFDA completes Nalagarh facility inspection: Wockhardt
Drug firm Wockhardt, which has been under the USFDA scanner, Thursday said that United States health regulator has completed inspection of its Nalagarh facility in Himachal Pradesh.
Jul 23, 2015, 20:34 PM IST
Wockhardt recalls over 1.62 lakh cartons of drugs in US
As per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
Jul 16, 2015, 19:05 PM IST
Wockhardt surges 3% on USFDA nod to market pain-relieving drug
Shares of drug firm Wockhardt rose by nearly 3 percent on Monday as the company received approval from the US health regulator to market its Oxycodone HCl liquid, used for treating chronic pain, in the American market.
Jun 22, 2015, 19:34 PM IST
Two drugs manufactured by Wockhardt recalled in the US
According to information on the US Food and Drug Administration (USFDA) website, 166 bottles of Captopril tablets of 50 mg strength are being recalled in the US.
Jun 05, 2015, 19:22 PM IST
Wockhardt hopeful of early resolution of USFDA row
The company has now increased its R&D spend and filed more ANDAs in the US and Britain for approvals.
May 29, 2015, 16:25 PM IST
USFDA completes Waluj facility inspection: Wockhardt
Drug firm Wockhardt, which has been under the USFDA's scanner, Wednesday said that the American health regulator has completed the inspection of its Waluj facility in Maharashtra.
May 27, 2015, 20:59 PM IST
Wockhardt recalls 93K bottles of Captopril tablets from US
Recall has been initiated as the tablets failed to meet tablet/capsule specifications given by the USFDA.
May 14, 2015, 17:40 PM IST
Wockhardt shares slump over 6% on recall of some drugs
After falling 11.2 percent to Rs 1,181 in intra-day trade on the BSE, shares of the company finally ended at Rs 1,243.35, down 6.52 percent.
Apr 28, 2015, 18:16 PM IST
Wockhardt recalls 13 drugs in US after FDA concerns
Pharmaceuticals major Wockhardt is recalling 13 drugs in the US, manufactured at its two units at Chikalthana and Waluj in Maharashtra, which were under import restrictions from the USFDA.
Apr 28, 2015, 10:37 AM IST
US FDA did not find issues with Wockhardt's Chikalthana plant
"The recent inspection at the Aurangabad L1-Chikalthana site was a follow-up inspection by the US FDA as an outcome of completion of good manufacturing practise (GMP) remediation submitted by Wockhardt in October 2014.
Mar 18, 2015, 19:03 PM IST
Wockhardt says FDA raises new concerns about Waluj plant
Shares in Wockhardt Ltd fell as much as 5.3 percent on Thursday after the drugmaker said the U.S. Food and Drug Administration had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.
Feb 26, 2015, 16:41 PM IST
Wockhardt drug discovery gets fast track approval by USFDA
This is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued here.
Sep 01, 2014, 08:16 AM IST
USFDA grants QIDP status to two Wockhardt drugs
Drug maker Wockhardt on Sunday said that two of its anti-infective drugs have received Qualified Infectious Disease Product (QIDP) status from the US health regulator.
Aug 31, 2014, 19:08 PM IST
